• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

A colorimetric assay for measuring the lysis of a plasma clot.

作者信息

Mao S J, Tucci M A

机构信息

Merrell Dow Research Institute, Cincinnati, Ohio 45215.

出版信息

Anal Biochem. 1991 Jan;192(1):6-10. doi: 10.1016/0003-2697(91)90174-r.

DOI:10.1016/0003-2697(91)90174-r
PMID:1828653
Abstract

The present study describes a simple, quantitative assay for measuring the lysis of a plasma clot. The principle of the assay is based on the release of Coomassie brilliant blue R-250 dye from the clot. Thirty microliters of freshly prepared Coomassie brilliant blue R-250 (1 mg/ml) was added to 200 microliters of diluted human plasma (1:5). After mixing, 100 microliters of thrombin (2.5 NIH units/ml) were added to mediate a plasma clot. One milliliter of streptokinase (0.1 mg/ml) was used as a plasminogen activator to initiate clot lysis. During the course of lysis, 100 microliters of soluble material were transferred to microtiter wells and the absorbance at 540 nm was determined as a measure of clot lysis. This assay was used to measure clot lysis in 18 human plasma samples. The colorimetric method (X) developed in this report correlated well with that determined using a conventional 125I-fibrinogen method (Y): Y = 0.83X + 7.98 (r = 0.91).

摘要

相似文献

1
A colorimetric assay for measuring the lysis of a plasma clot.
Anal Biochem. 1991 Jan;192(1):6-10. doi: 10.1016/0003-2697(91)90174-r.
2
Vampire bat salivary plasminogen activator promotes robust lysis of plasma clots in a plasma milieu without causing fluid phase plasminogen activation.吸血蝙蝠唾液纤溶酶原激活剂可在血浆环境中促进血浆凝块的强力溶解,而不会引起液相纤溶酶原激活。
Thromb Haemost. 1992 Aug 3;68(2):165-9.
3
Lipoprotein(a) enhances plasma clot lysis in vitro.
FEBS Lett. 1990 Jul 2;267(1):131-4. doi: 10.1016/0014-5793(90)80306-4.
4
Assessment of fibrinolytic activity by measuring the lysis time of a tissue-factor-induced clot: a feasibility evaluation.通过测量组织因子诱导的凝块的溶解时间来评估纤维蛋白溶解活性:可行性评估。
Clin Appl Thromb Hemost. 2010 Jun;16(3):337-44. doi: 10.1177/1076029608325542. Epub 2008 Dec 30.
5
A STANDARD CLOT METHOD FOR THE ASSAY OF PLASMINOGEN ACTIVATORS, ANTI-ACTIVATORS, AND PLASMIN.一种用于测定纤溶酶原激活剂、抗激活剂和纤溶酶的标准凝血方法。
J Clin Pathol. 1964 Mar;17(2):175-81. doi: 10.1136/jcp.17.2.175.
6
In vitro comparison of fibrinolytic activity of plasminogen activators using a thrombelastographic method: in vivo evaluation of the B-chain-streptokinase complex in the dog model using pre-titered doses.使用血栓弹力图法对纤溶酶原激活剂的纤溶活性进行体外比较:在犬模型中使用预滴定剂量对B链-链激酶复合物进行体内评估。
Thromb Haemost. 1986 Aug 20;56(1):71-9.
7
Analysis of five streptokinase formulations using the euglobulin lysis test and the plasminogen activation assay.使用优球蛋白溶解试验和纤溶酶原激活试验对五种链激酶制剂进行分析。
Braz J Med Biol Res. 2004 Dec;37(12):1889-94. doi: 10.1590/s0100-879x2004001200015. Epub 2004 Nov 17.
8
Thrombin activatable fibrinolysis inhibitor (TAFI) affects fibrinolysis in a plasminogen activator concentration-dependent manner. Study of seven plasminogen activators in an internal clot lysis model.凝血酶激活的纤溶抑制物(TAFI)以纤溶酶原激活物浓度依赖的方式影响纤维蛋白溶解。在内源性凝块溶解模型中对七种纤溶酶原激活物的研究。
Thromb Haemost. 2004 Mar;91(3):473-9. doi: 10.1160/TH03-06-0377.
9
Studies on activator formation in human plasma with streptokinase. III. Investigation of activator kinetics in undiluted plasma in terms of urokinase equivalents.关于链激酶在人血浆中激活剂形成的研究。III. 根据尿激酶当量对未稀释血浆中激活剂动力学的研究。
Thromb Haemost. 1976 Dec 31;36(3):566-81.
10
Kinetics of plasma coagulation and lysis I: Basic kinetic model for time course of coagulation-lysis systems and its potential application to clinical studies.血浆凝血与纤溶动力学I:凝血-纤溶系统时间进程的基本动力学模型及其在临床研究中的潜在应用。
J Pharm Sci. 1978 Feb;67(2):145-51. doi: 10.1002/jps.2600670206.

引用本文的文献

1
Production of recombinant streptokinase from Streptococcus pyogenes isolate and its potential for thrombolytic therapy.从化脓性链球菌分离物中生产重组链激酶及其溶栓治疗潜力。
Saudi Med J. 2014 Dec;35(12):1482-8.